PhD defence by Peter Hammer Guldager Egelund
Development of a Fragment Ligation Platform for Large-Scale Manufacture of Therapeutic Peptides and Proteins
Assessment committee
(Chairperson) Professor Kristian Strømgaard, University of Copenhagen
Professor Kurt V. Gothelf, Aarhus University, Denmark
Professor Philip E. Dawson, The Scripps Research institute, US
Supervisors
Professor Christian Adam Olsen, University of Copenhagen
Dr Daniel Sejer Pedersen, Novo Nordisk A/S
Department
Department of Drug Design and Pharmacology
Graduate programme
Pharmaceutical Sciences
Place of study
The experimental work took place at the Department of Drug Design and Pharmacology, University of Copenhagen, and at CMC API chemical development 3, Novo Nordisk A/S
Place of PhD defence
Auditorium 3
Building 12
PharmaSchool
Universitetsparken 2
2100 Copenhagen
Ask for a copy of the thesis
peter.egelund@live.dk